Goldman Sachs’s Larkspur Health Acquisition Corp. Unit LSPRU Stock Holding History

Goldman Sachs’s Portfolio LSPRU Stock Details LSPRU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,258	Closed	-$645K	–	6516
2022 Q3	$645K	Sell	64,258 -22,300	-26%	-$225K	﹤0.01%	4805
2022 Q2	$864K	Hold	86,558	–	–	﹤0.01%	4724
2022 Q1	$866K	Hold	86,558	–	–	﹤0.01%	4938
2021 Q4	$867K	Buy	+86,558	New	+$865K	﹤0.01%	4969

Goldman Sachs's LSPRU Position: Q4 2022 in Review

Goldman Sachs sold out of Larkspur Health Acquisition Corp. Unit (LSPRU) in Q4 2022, closing a stake of 64,258 shares — an estimated $645K sold.

Goldman Sachs first reported a position in LSPRU in Q4 2021 and held it in 4 quarters. The position peaked at $867K in Q4 2021. 0 funds tracked by Wall St. Rank hold LSPRU as of Q4 2022.

Goldman Sachs reported no remaining Larkspur Health Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 64,258 Larkspur Health Acquisition Corp. Unit shares in Q4 2022, an estimated $645K.
Goldman Sachs first reported a position in Larkspur Health Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
Goldman Sachs's Larkspur Health Acquisition Corp. Unit position peaked at $867K in Q4 2021.
0 funds tracked by Wall St. Rank held Larkspur Health Acquisition Corp. Unit as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.